1. Home
  2. MODD vs CVKD Comparison

MODD vs CVKD Comparison

Compare MODD & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MODD
  • CVKD
  • Stock Information
  • Founded
  • MODD 1998
  • CVKD 2022
  • Country
  • MODD United States
  • CVKD United States
  • Employees
  • MODD N/A
  • CVKD N/A
  • Industry
  • MODD Industrial Specialties
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • MODD Health Care
  • CVKD Health Care
  • Exchange
  • MODD Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • MODD 35.5M
  • CVKD N/A
  • IPO Year
  • MODD N/A
  • CVKD 2023
  • Fundamental
  • Price
  • MODD $1.10
  • CVKD $18.46
  • Analyst Decision
  • MODD
  • CVKD Strong Buy
  • Analyst Count
  • MODD 0
  • CVKD 1
  • Target Price
  • MODD N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • MODD 126.9K
  • CVKD 37.3K
  • Earning Date
  • MODD 02-13-2025
  • CVKD 03-13-2025
  • Dividend Yield
  • MODD N/A
  • CVKD N/A
  • EPS Growth
  • MODD N/A
  • CVKD N/A
  • EPS
  • MODD N/A
  • CVKD N/A
  • Revenue
  • MODD N/A
  • CVKD N/A
  • Revenue This Year
  • MODD N/A
  • CVKD N/A
  • Revenue Next Year
  • MODD N/A
  • CVKD N/A
  • P/E Ratio
  • MODD N/A
  • CVKD N/A
  • Revenue Growth
  • MODD N/A
  • CVKD N/A
  • 52 Week Low
  • MODD $0.68
  • CVKD $5.40
  • 52 Week High
  • MODD $2.65
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • MODD 57.69
  • CVKD 48.88
  • Support Level
  • MODD $1.05
  • CVKD $17.43
  • Resistance Level
  • MODD $1.29
  • CVKD $19.96
  • Average True Range (ATR)
  • MODD 0.12
  • CVKD 1.46
  • MACD
  • MODD 0.04
  • CVKD 0.01
  • Stochastic Oscillator
  • MODD 62.75
  • CVKD 66.43

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: